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Chapter 11
Transposon Mutagenesis in Mycobacterium avium
Subspecies Paratuberculosis
John P. Bannantine, Denise K. Zinniel, and Rau´l G. Barletta
Abstract
While transposon mutagenesis has been developed for Mycobacterium avium subspecies paratuberculosis
(Map), relatively few laboratories have adopted this important genetic tool to examine gene function and
essentiality. Here we describe the construction of a Map transposon library using the Himar1 mariner
transposon, but concepts can also be applied to the Tn5367 transposon, which has also been used by our
group. Delivery of the transposon is by a temperature-sensitive phagemid, ϕMycoMarT7, and plating
transductants requires patience and specialized media due to length of incubation required to observe
colonies. Several transposon mutants obtained from these libraries have been tested in vaccine and
pathogenesis studies. By providing the following detailed protocol herein, we expect to demystify the
procedure and encourage additional investigators to incorporate transposon mutagenesis in their studies on
Johne’s disease.
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1 Introduction
Mycobacterium avium subspecies paratuberculosis (Map) causes
Johne’s disease in cattle, sheep, goats, and other ruminants. It is
among the slowest growing mycobacteria with a generation time of
approximately 24 h and some strains, especially those isolated from
sheep, are difficult to culture. These factors have combined to delay
advancements in genetic studies ofMap relative to other mycobac-
teria including M. smegmatis and M. tuberculosis, especially as it
relates to vaccine strain construction and essential gene analysis.
The first efforts to genetically modify Map came with the
discovery that mycobacteriophage TM4 could form plaques on
Map lawns [1]. Soon after, a TM4 derivative, phAE94, was engi-
neered to deliver the Tn5367 transposon randomly into the Map
genome [2]. Tn5367 is derived from IS1096 from M. smegmatis
[3]. With this technology in hand, a library of over 5000 transpo-
son mutants was initially constructed [2], and later, 13,500 Tn5367
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mutants of Map were obtained [4]. Directed knockouts using
insertion sequences have now also been achieved inMap. Examples
of genes that have been targeted using this method include sigH
[5, 6], lipN [5], leuD [7], relA, lsr2, and pknG [8], with relA [9]
and leuD [10] mutants showing protection from Map challenge in
goats.
More recently, our group compared the total genome inser-
tions sites for the mycobacterial transposon Tn5367 with the mari-
ner transposon MycoMarT7 carrying the Himar1 transposase
[11]. The dinucleotide insertion recognition site (50-TA-30) for
MycoMarT7 was significantly more prevalent than the degenerate
tetramer (50-NNPy[A/T]A[A/T]NN-30) Tn5367 recognition sites
such that only 37 genes do not contain a MycoMarT7 site, com-
pared to 710 genes missing Tn5367 sites. Therefore, transposons
containing the IS1096 element have recognition site distribution
biases that could affect the interpretation of gene essentiality on a
whole genome basis. Nonetheless, this transposon has been useful
for single gene studies and mutant library selection under defined
conditions [4, 12–15].
Tn5367 carries a kanamycin-resistance marker and can be deliv-
ered to Map by a thermosensitive phagemid phAE94 derived from
mycobacteriophage TM4 [1, 16]. Whereas, MycoMarT7 is a
Himar1-derived transposon that also carries a kanamycin-
resistance marker engineered into the same TM4 phagemid, desig-
nated ϕMycoMarT7 [17, 18]. Here we describe the detailed pro-
tocols for obtaining a Himar1 transposon library in Map.
2 Materials
For transposon mutagenesis, the only two strains ofMap used thus
far are the type strain (ATCC19698) and the bovine clinical isolate
K-10. Other Map stains are expected to be amendable to the
genetic manipulations described here, although ovine isolates will
be more fastidious to grow in the laboratory [19].
1. Middlebrook 7H9 medium: Dissolve 4.7 g of Difco™ 271310
Middlebrook 7H9 powder (Becton, Dickinson and Company)
in 900ml distilled H2O and 2ml of glycerol. ForMap, use HCl
to adjust the pH to 5.9. If preparing culture media for petri
dish applications, microbiological agar (15 g/l) is added. Auto-
clave at 121 C for 20 min with slow exhaust. Cool to 50 C
(see Note 1) in order to add supplements (e.g., Tween™
80, cycloheximide, albumin–dextrose–catalase (ADC; BBL™
Middlebrook 212352; Becton, Dickinson and Company), oleic
acid–albumin–dextrose–catalase (OADC; BBL™Middlebrook
212240; Becton, Dickinson and Company), mycobactin J
(Allied Monitor, Inc.)) and any desired antibiotic(s) for
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selection. Under sterile conditions, add 2.5 ml of 20% Tween™
80, 10 ml of 1% cycloheximide and 100 ml of ADC (M. smeg-
matis). For Map, add 2.5 ml of 20% Tween™ 80, 10 ml of 1%
cycloheximide, 1 mg of mycobactin J, and 100 ml of OADC
instead of ADC. Tween™ 80 is not added if preparing agar (see
Note 2).
2. Middlebrook 7H10 agar medium: Dissolve 19 g of Difco™
262710 Middlebrook 7H10 powder (Becton, Dickinson and
Company) in 900 ml distilled H2O and 5 ml of glycerol.
Autoclave at 121 C for 20 min with slow exhaust. Cool to
50 C and add supplements and/or antibiotic(s) as listed above
(see Subheading 2, item 1).
3. Mycobacterial phage (MP) buffer: ForM. smegmatis, the stan-
dard composition is 50 mMTris–HCl, pH 7.5; 150 mMNaCl;
10 mM MgSO47H2O; and 2 mM CaCl2. For Map, the com-
ponents are 50 mM Tris–HCl, pH 7.6; 150 mMNaCl; 10 mM
MgCl2; and 2 mM CaCl2. These both can be stored up to
1 year at room temperature.
4. Phage soft agar: media is prepared as stated above (see Sub-
heading 2, item 1 or 2) depending on the bacterial source
except that 7 g/l of microbiological agar is added.
5. Adsorption-stop buffer: MP buffer containing 20 mM sodium
citrate and 0.2% Tween™ 80. This solution is added to prevent
further phage infections after completion of the
adsorption time.
6. 50% glycerol-PBS freezing solution: 2 mM NaH2PO4, 4 mM
Na2HPO4, 4 mM NaCl, and 50% glycerol (vol/vol).
3 Methods
3.1 Mycobacterial
Culture
1. Inoculate a 2-l flask containing 500 ml of Middlebrook 7H9 at
pH 5.9 supplemented with 0.2% glycerol, OADC, 0.05%
Tween™ 80, 1 mg mycobactin J and 0.01% cycloheximide
(see Subheading 2, item 1). Use a single, well isolated colony
of the Map strain of choice for the inoculum.
2. Incubate culture stagnant for 4 weeks checking optical density
at 540 nanometers (O.D. 540nm) after the third and
fourth week.
3. Harvest 50-ml aliquots of cultures in mid-log phase (O.-
D.540 nm ¼ 0.4 to 0.75) by centrifugation at 4420  g for
25 min. This optical density equates to approximately
2.0  108 cfu/ml.
4. If preparing a fresh stock of the phagemid, start the phagemid
preparation protocol (Subheading 3.2) during the fourth week
of growing the Map culture.
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3.2 Phagemid
Preparation
The phagemid ϕMycoMarT7 must be propagated and titered using
freshly grown M. smegmatis cells at 30 C.
1. Grow approximately 10 ml of M. smegmatis mc2155 shaking
overnight at 37 C in Middlebrook 7H9 media supplemented
with 0.2% glycerol, ADC, 0.05% Tween™ 80 and 0.01% cyclo-
heximide (see Subheading 2, item 1).
2. From a known ϕMycoMarT7 titer number, make appropriate
dilutions inMP buffer. For example, phagemid at a titer of 1010
plaque-forming units (PFU)/ml will usually have a “lace”
pattern (plaques are touching) at 106 that is used for propa-
gation and countable plaques are determined at the 108 dilu-
tion. The final dilution should be made several times
depending on how much phage needs to be propagated (see
Note 3).
3. Mix the M. smegmatis mc2155 culture with the phagemid
dilution in a 2:1 volume ratio (e.g., 2 ml of culture with 1 ml
diluted phagemid).
4. Incubate standing at 30 C for 30 min to allow for adsorption.
5. Add 300 μl of the phagemid–cell mixture to 3.5 ml of phage
soft agar (see Subheading 2, item 4) and gently mix by rolling
the tube with your palms. It is important to keep the phage soft
agar at 56 C until ready to use in a glass tube in a heat block.
6. Pour each tube of phage soft agar containing phagemid–cell
mixture onto separate Middlebrook 7H9 agar plates (see
Note 4). Quickly rotate the plate in a circular motion to evenly
spread the agar over the entire surface. Once solidified, invert
the plates to prevent condensation.
7. Incubate at 30 C overnight or until plaques are visible
(2–3 days).
8. Once plaques are produced and clearly visible, flood each plate
with 5 ml of MP buffer. These plates are then incubated at 4 C
for 2–4 h followed by incubation at 37 C for 1–2 h (see
Note 5).
9. Collect the liquid from each plate by pipetting or scraping the
top agar off with an L-spreader and pooling in an Oak Ridge
centrifuge tube. It is important to use as little buffer as possible
so as to not dilute the new stock.
10. Centrifuge for 30 min at 23,300  g at 4 C to remove agar
pieces and bacterial debris. The phagemid stock should now be
clarified.
11. Filter phage stock with a 0.45 μm filter and store at 4 C (crude
phage stock). To further purify the crude phage stock, if
needed, ultracentrifuge at 82,705  g for 6 h at 4 C using a
SW28 rotor. Dissolve pellet in MP buffer 200 μl and wash with
50–100 μl of 2 MP buffer (see Note 6).
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12. Titer new phage stock to determine its concentration (see
Note 7). This is done by plating phagemid dilutions on
M. smegmatis cells. Ideally, the titer should be at least
1  1010 PFU per ml or better.
3.3 Transductions A schematic representation of the entire transduction and collec-
tion procedure encompassing Subheadings 3.3–3.5 are depicted in
Fig. 1.
1. Add 1 ml of MP buffer to theMap bacteria concentrated from
step 3 of Subheading 3.1.
2. Infect Map (1.0  107 CFU in 0.1 ml) with 0.1 ml of
φMycoMarT7 at 1.0  108 PFU (see Note 8) to have a multi-
plicity of 10 PFU per bacterium, based on the phage titer
determined at the permissive temperature for propagation
(30 C). Set up multiple aliquots if plating multiple plates
(1 for each plate). Also have separate control tubes with just
bacteria and phage.
3. Leave the Map and phagemid mixture incubating at 37 C
overnight. At the nonpermissive temperature (37 C), the
phage acts as a nonlytic transducing phage for transposon
delivery into Map.
Fig. 1 Flow diagram showing the steps on how to generate a Map MycoMarT7 mutant library. The left side of
the flow diagram shows the transduction sets to be pooled and stocked while the right side shows the mock
transductions (without phage) to determine percentage of spontaneous kanamycin resistance
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4. Add an equal volume of stop buffer, wait 5 min and immedi-
ately proceed to plating in the next section.
3.4 Plating
Transposon Mutants
1. Independent transductions can be performed and plated sepa-
rately to obtain a collection of insertional mutants. Alterna-
tively, colonies can be pooled from several independent
transductions to obtain a highly representative insertional
library.
2. Plate 0.1 ml volumes of the stopped transduction mixture on
Middlebrook 7H10 plates supplemented with 0.5% glycerol,
0.01% cycloheximide, 1 mg of mycobactin J and OADC with-
out Tween 80, but containing either 50 μg/ml kanamycin. Use
a bent glass rod “hockey stick” or L-spreader to disperse the
aliquot over the entire surface of the plate (see Note 4).
3. Individual kanamycin-resistant transductants are randomly
picked after an 8 week incubation period at 37 C.
4. The entire library can be harvested and stocked in 50%
glycerol-PBS freezing solution. The library can be stored in
0.5-ml aliquots at 80 C.
3.5 Harvesting
Colonies Representing
Transposon Mutants
1. Colonies can be picked individually or harvested together
depending on the goal of the experiment.
2. If picking and stocking individual colonies separately, these can
be picked using a sterile needle into 96-well plates containing
Middlebrook 7H9 media (0.2 ml).
3. If harvesting together, flood the plates with either MP buffer or
Middlebrook 7H9 media and concentrate mutants by
centrifugation.
4. DNA can then be extracted for Tn-seq analysis or individually
stocked mutants can be screened for various phenotypic traits.
4 Notes
1. The ADC/OADC supplement is purchased commercially, fil-
tered through a 0.2 μm filter assembly and added to the
autoclaved-sterilized Middlebrook 7H9 media. Note that
ADC/OADC is only added after the media has cooled below
50 C. Bacteriological media for plating transductions should
be prepared fresh 2 days before the experiment and allowed to
dry in a 37 C incubator to prevent water accumulation from
condensation. Alternatively for Middlebrook 7H9 and 7H10
media preparation, ADC/OADC can be made from scratch
with additional details found in Chacon et al. [20] and Larsen
et al. [21]. For the growth of M. smegmatis mc2155 and Map
K-10, the addition of catalase and cycloheximide to these
media is optional.
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2. Tween™ 80 helps prevent clumping, which is not necessary
when plating on solid media.
3. High titer lysates are used for propagation of phage when large
amounts of phage are needed for transductions. Examples
include replenishing working stocks, phage purification, or
phage DNA isolation.
4. Solid media petri plates come in various sizes but the most
common is 100 mm  15 mm (60 cm2 area) can be sealed
with paraffin to prevent drying.
5. The phagemid will diffuse into the MP buffer during the
overnight incubation. The plates can be kept stagnant or on a
slow rocking platform. The phage soft agar will shrink at 4 C
and then expand under the 37 C temperature to help release
the phage Larsen et al. [21].
6. Keep the mycobacteriophage in two stock vials: working stock
and back-up stock. Then only use from the working stock
bottles and keep the back-up vial only for repropagation of
phage when the working stock is depleted or has developed a
problem such as contamination.
7. All phage stocks must be kept in the refrigerator at 4 C. If the
phage must be taken out of the refrigerator for any length of
time, then the phage should be placed on ice. Temperature
variations will cause a phage titer to decrease.
8. When using the phage stocks, extreme care must be used to
prevent contamination of the stocks. We suggest wearing
alcohol-rinsed latex gloves, wiping the phage stock bottle off
with alcohol tissue and allowing it to dry thoroughly, using
fresh sterile pipet tips every time an aliquot is taken from the
phage stock bottle, and wrapping the bottle lid with paraffin
before returning to 4 C storage.
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